Stock listing

Protara Therapeutics, Inc.

Selected listing: 1KPA · HAM · EUR · DE

Protara Therapeutics, Inc. (Hamburg:1KPA), Health Technology. Latest release Sep 8, 2026: Protara Therapeutics to Present at the H.C. Wainwright 28th Annual…

1KPA:HAMEURDEUpdated October 2, 2026

Ticker: Hamburg:1KPA
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: Hamburg
Currency: EUR

Latest news from Protara Therapeutics, Inc.

Protara Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference

September 8, 2026

Protara Therapeutics Announces Second Quarter 2026 Financial Results and Provides a Business Update

August 11, 2026

Protara Therapeutics to Present at the TD Cowen 7th Annual Oncology Innovation Summit: Insights for ASCO & EHA

May 20, 2026

Protara Therapeutics to Host Virtual Investor Webinar to Discuss TARA-002 for Lymphatic Malformations on Tuesday, May 19, 2026

May 18, 2026

Protara Therapeutics Announces Positive Updated 12-Month Data Demonstrating Durable Responses in the Fully Enrolled BCG-Naïve Cohort of the Ongoing Phase 2 ADVANCED-2 Trial of TARA-002 in NMIBC

May 15, 2026

All Protara Therapeutics, Inc. news →

Events

Replays

Protara Therapeutics, Inc. (TARA) Q1 2026 Earnings Call
Tue, May 19, 2026 · 04:30 PM ET
Watch

Research Protara Therapeutics, Inc.

Protara Therapeutics, Inc. company profile

View the public company page for Protara Therapeutics, Inc. on 6ix.

Protara Therapeutics, Inc. news

Read company news and market updates connected to Protara Therapeutics, Inc..

Protara Therapeutics, Inc. investor events

Find investor webinars, events, and replay context for Protara Therapeutics, Inc..